Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

限制酶分析和简单疹感染

S E Barton, P E Munday, J M Davis

    Lancet (London, England)
    |June 22, 1985
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].

    Antiviral chemistry & chemotherapy·2000
    Same author

    Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.

    Antiviral chemistry & chemotherapy·1999
    Same author

    Isolation and characterization of the fungal metabolite 3-O-methylviridicatin as an inhibitor of tumour necrosis factor alpha-induced human immunodeficiency virus replication.

    Antiviral chemistry & chemotherapy·1999
    Same author

    MDL 74,968, a new acyclonucleotide analog: activity against human immunodeficiency virus in vitro and in the hu-PBL-SCID.beige mouse model of infection.

    Antimicrobial agents and chemotherapy·1996
    Same author

    Potent inhibition of human immunodeficiency virus by MDL 101028, a novel sulphonic acid polymer.

    Antiviral research·1995
    Same author

    The ribonucleotide reductase inhibitor (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731): a potential topical therapy for herpes simplex virus infection.

    Antiviral research·1995